Literature DB >> 11177742

Therapeutic approaches to metastasis confined to the liver.

A P Venook1, R S Warren.   

Abstract

Liver metastases nearly always represent disseminated cancer, and systemic therapies are usually indicated. However, in a minority of patients--some with colorectal cancer, others with selected tumors--management of the hepatic disease may be clinically important and even curative. This review identifies unique patient subgroups and novel treatment approaches that may be indicated in patients with liver metastases.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11177742     DOI： 10.1007/s11912-001-0009-4

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN： 1523-3790            Impact factor:   5.945


  46 in total

Review 1.  Update on hepatic intra-arterial chemotherapy.

Authors:  A P Venook
Journal:  Oncology (Williston Park)       Date:  1997-07       Impact factor: 2.990

2.  Hepatic artery chemoembolization for management of patients with advanced metastatic carcinoid tumors.

Authors:  J G Drougas; L B Anthony; T K Blair; R R Lopez; J K Wright; W C Chapman; L Webb; M Mazer; S Meranze; C W Pinson
Journal:  Am J Surg       Date:  1998-05       Impact factor: 2.565

3.  A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases.

Authors:  A E Chang; P D Schneider; P H Sugarbaker; C Simpson; M Culnane; S M Steinberg
Journal:  Ann Surg       Date:  1987-12       Impact factor: 12.969

4.  Pharmacologic rationale for regional drug delivery.

Authors:  J M Collins
Journal:  J Clin Oncol       Date:  1984-05       Impact factor: 44.544

5.  Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients.

Authors:  S A Curley; F Izzo; P Delrio; L M Ellis; J Granchi; P Vallone; F Fiore; S Pignata; B Daniele; F Cremona
Journal:  Ann Surg       Date:  1999-07       Impact factor: 12.969

6.  A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial.

Authors:  D C Hohn; R J Stagg; M A Friedman; J F Hannigan; A Rayner; R J Ignoffo; P Acord; B J Lewis
Journal:  J Clin Oncol       Date:  1989-11       Impact factor: 44.544

7.  Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma.

Authors:  N Kemeny; J A Conti; A Cohen; P Campana; Y Huang; W J Shi; J Botet; S Pulliam; J R Bertino
Journal:  J Clin Oncol       Date:  1994-11       Impact factor: 44.544

8.  Gastrointestinal leiomyosarcoma metastatic to the liver. Durable tumor regression by hepatic chemoembolization infusion with cisplatin and vinblastine.

Authors:  G M Mavligit; A A Zukwiski; L M Ellis; V P Chuang; S Wallace
Journal:  Cancer       Date:  1995-04-15       Impact factor: 6.860

9.  A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer.

Authors:  N Kemeny; K Seiter; D Niedzwiecki; D Chapman; E Sigurdson; A Cohen; J Botet; P Oderman; P Murray
Journal:  Cancer       Date:  1992-01-15       Impact factor: 6.860

10.  The relationship between hospital volume and outcomes of hepatic resection for hepatocellular carcinoma.

Authors:  R E Glasgow; J A Showstack; P P Katz; C U Corvera; R S Warren; S J Mulvihill
Journal:  Arch Surg       Date:  1999-01
View more
  1 in total

1.  Value of Virtual Colonoscopy with 64 Row CT in Evaluation of Colorectal Cancer.

Authors:  Urszula Zaleska-Dorobisz; Mateusz Lasecki; Ewa Nienartowicz; Joanna Pelak; Joanna Słonina; Cyprian Olchowy; Marek Scieżka; Marek Sąsiadek
Journal:  Pol J Radiol       Date:  2014-09-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.